FMS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 01:30):

Stats
आज की मात्रा	232 364
औसत मात्रा	460 157
बाजार मूल्य	12.71B
EPS	$0 ( 2024-02-20 )
अगली कमाई की तारीख	( $0.279 ) 2024-05-22
Last Dividend	$0.618 ( 2023-05-17 )
Next Dividend	$0 ( N/A )
P/E	23.80
ATR14	$0.0100 (0.05%)

मात्रा सहसंबंध

लंबा: 0.58 (weak)

छोटा: 0.65 (moderate)

Signal:(71.829) Neutral

Fresenius Medical Care AG सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
DMYS	0.973
CXAC	0.97
ALCC	0.962
AFTR	0.96
BMAC	0.96
MTVC	0.959
MTH	0.959
TRCA	0.958
BSAQ	0.957
PNTM	0.957

10 सबसे अधिक नकारात्मक सहसंबंध
GRUB	-0.954
PAK	-0.953
CCOR	-0.94
UNL	-0.936
TPL	-0.936
DBMF	-0.933
RSF	-0.931
UNG	-0.931
GAZ	-0.931
RKLY	-0.93

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Fresenius Medical Care AG सहसंबंध - मुद्रा/वस्त्र

-0.54
( weak negative )

-0.67
( moderate negative )

0.00
( neutral )

0.16
( neutral )

0.22
( neutral )

Fresenius Medical Care AG वित्तीय

Annual	2023
राजस्व:	$19.45B
सकल लाभ:	$4.93B (25.32 %)
EPS:	$1.700

FY	2023
राजस्व:	$19.45B
सकल लाभ:	$4.93B (25.32 %)
EPS:	$1.700

FY	2022
राजस्व:	$19.40B
सकल लाभ:	$5.31B (27.37 %)
EPS:	$2.30

FY	2021
राजस्व:	$17.62B
सकल लाभ:	$5.08B (28.82 %)
EPS:	$1.655

Financial Reports:

No articles found.

Fresenius Medical Care AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.618 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fresenius Medical Care AG Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.71 - Decrease likely (25.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0930	1998-06-08
Last Dividend	$0.618	2023-05-17
Next Dividend	$0	N/A
Payout Date	2023-06-01
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	$10.47	--
Avg. Dividend % Per Year	1.85%	--
Score	3.72	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.71
Div. Directional Score	7.38	--

Next Divdend (Est)
(2025-04-02)

$0.626 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.72

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
1998	$0.0930	0.85%
1999	$0.104	0.86%
2000	$0.111	0.80%
2001	$0.121	0.87%
2002	$0.125	1.21%
2003	$0.168	2.48%
2004	$0.253	2.11%
2005	$0.239	1.79%
2006	$0.244	1.35%
2007	$0.314	1.39%
2008	$0.416	1.58%
2009	$0.375	1.57%
2010	$0.408	1.50%
2011	$0.475	1.65%
2012	$0.456	1.30%
2013	$0.490	1.43%
2014	$0.533	1.53%
2015	$0.438	1.20%
2016	$0.440	1.07%
2017	$0.514	1.21%
2018	$0.632	1.21%
2019	$0.655	2.01%
2020	$0.707	1.91%
2021	$0.834	1.96%
2022	$0.709	2.17%
2023	$0.618	3.84%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0281	1.500	9.44	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0161	1.200	9.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0398	1.500	-0.669	-1.004	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.424	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.45	[0.8 - 2.5]
cashRatioTTM	0.230	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0.355	-1.500	4.08	-6.12	[0 - 0.6]
interestCoverageTTM	3.47	1.000	9.83	9.83	[3 - 30]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.63	2.00	6.69	10.00	[0 - 20]
debtEquityRatioTTM	0.885	-1.500	6.46	-9.69	[0 - 2.5]
grossProfitMarginTTM	0.253	1.000	9.11	9.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.0710	1.000	-0.580	-0.580	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.218	1.000	9.90	9.90	[0.2 - 2]
assetTurnoverTTM	0.573	0.800	9.51	7.61	[0.5 - 2]
Total Score				11.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.63	1.000	9.03	0	[1 - 100]
returnOnEquityTTM	0.0398	2.50	-0.430	-1.004	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.63	2.00	7.79	10.00	[0 - 30]
dividendYielPercentageTTM	3.12	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.823	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.135	1.000	9.12	0	[0.1 - 0.5]
Total Score				3.71

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.